Overview of Dr. Russo
Dr. Paul Russo is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 38 years. He is one of 71 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 100 publications and over 500 citings.
Office
MSK Sidney Kimmel Center for Prostate and Urologic Cancers
353 East 68th Street
New York, NY 10021- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Cancer Biology, 1986 - 1988
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1984 - 1988
- Washington University/B-JH/SLCH ConsortiumResidency, Urology, 1981 - 1984
- Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 1979 - 1981
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
Certifications & Licensure
- NY State Medical License 1988 - 2025
- NJ State Medical License 2021 - 2025
- CT State Medical License 2023 - 2024
- American Board of Urology Urology
Awards, Honors, & Recognition
- New York City Best Doctors Castle Connelly, 2000-2016
- Fellow (FACS) American College of Surgeons
- Super Doctor SuperDoctors.com
Clinical Trials
- Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. Start of enrollment: 2005 Jun 01
Publications & Presentations
PubMed
- Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma.Matulewicz, R. S., Stephen W Reese, Lennert Eismann, Charlie White, Juan Arroyave Villada, Sari Khaleel, Irina Ostrovnaya, Katiana Vazquez-Rivera, Maria I Carlo, Darre...> ;Urologic Oncology. 2024 Feb 1
- Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized...Robert J Motzer, Paul Russo, Viktor Grünwald, Yoshihiko Tomita, Bogdan Zurawski, Omi Parikh, Sebastiano Buti, Philippe Barthélémy, Jeffrey C Goh, Dingwei Ye, Alejo Lin...> ;Targeted Oncology. 2023 Sep 1
- 1 citationsLocalised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.Kyle A Blum, Andrew W Silagy, Andrea Knezevic, Stanley Weng, Alan Wang, Roy Mano, Julian Marcon, Renzo G DiNatale, Alejandro Sanchez, Satish Tickoo, Sounak Gupta, Robe...> ;BJU International. 2024 Feb 1
- Join now to see all
Journal Articles
- Importance of Wide Re‐Resection in Adult Spermatic Cord Sarcomas: Report on Oncologic Outcomes at a Single InstitutionMassimiliano Spaliviero, Kaled M Alektiar, Harry W Herr, Paul Russo, Journal of Surgical Oncology
- Analysis of Renal Cancer Cell Lines from Two Major Resources Enables Genomics-Guided Cell Line SelectionSatish K Tickoo, Paul Russo, A Ari Hakimi, Victor E Reuter, James J Hsieh, Jonathan A Coleman, Michael Chevinsky, Christopher Jakubowski, Andrew G Winer, Nature
Authored Content
- Minerva Urologica E Nefrologica 2017 December;69(6):539-47August 2018
Press Mentions
- PN Risks May Outweigh Benefits in Some CKD CasesSeptember 3rd, 2020
- Does Cytoreductive Nephrectomy Remain an Essential Component of Care for Advanced Renal Cell Carcinoma?June 25th, 2019
- Factors Affecting Survival After Surgery for Locally Advanced RCCJune 3rd, 2015
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Society of Urological OncologyMember
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
- Memorial Hospital for Cancer and allied DiseasesBasking Ridge, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: